Fil LTD United Therapeutics Corp Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Fil LTD holds 1,231 shares of UTHR stock, worth $432,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,231

Holding current value

$432,290

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $382,890 - $447,530	1,231 New	1,231 $441,000
Q4 2020 Feb 08, 2021	SELL	$101.87 - $151.79 $11,409 - $17,000	-112 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$107.15 - $126.84 $49.4 Million - $58.4 Million	-460,716 Reduced 99.98%	112 $13,000
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $640,746 - $813,444	-6,319 Reduced 1.35%	460,828 $50.2 Million
Q3 2018 Nov 09, 2018	BUY	$113.81 - $129.46 $345,071 - $392,522	3,032 Added 0.65%	467,147 $59.7 Million
Q2 2018 Aug 10, 2018	SELL	$101.14 - $118.31 $18.1 Million - $21.2 Million	-179,332 Reduced 27.87%	464,115 $52.5 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $189,976 - $269,237	1,772 Added 0.28%	643,447 $72.3 Million
Q4 2017 Feb 12, 2018	BUY	$118.58 - $151.28 $19.4 Million - $24.8 Million	163,633 Added 34.23%	641,675 $94.9 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $54.8 Million - $65.4 Million	478,042	478,042 $56 Million

Others Institutions Holding UTHR

# of Institutions

681

Shares Held

42.2M

Call Options Held

194K

Put Options Held

298K

Black Rock Inc. New York, NY

5.47M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.55 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.11 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$786 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account